Collection of personal information
Verdélite, by itself or through third parties, collects personal information and usage data from visitors to our website. This personal information is limited to a visitor’s name and email address that he or she may freely provide or, in the case of usage data about a visit to the site, the data may be collected automatically in the course of a visit to verdelite.ca.
Usage data can include the IP address and domain used to access our website, the type and version of browser used, the website the visitor came from to our site, entry and exit pages, website pages within verdelite.ca viewed by that IP address, and what country the visitor is from. Verdélite uses this information to assess its website’s performance.
Use of personal information
We collect personal contact information to be able to respond to visitors’ inquiries and comments, manage lists of email contacts, and send messages as well as to improve our website’s effectiveness. Email addresses will not be sold, rented or leased to 3rd parties. Email may be sent to inform visitors of news. We may also use visitors’ personal information as required or permitted by applicable law or regulatory requirements, or for any additional purposes for which we have obtained a visitor’s consent.
Verdélite – or owners of third-party service that we use — may put a “cookie” on the hard drive of a visitor’s computer to make a record his or her visit. A cookie allows us to better understand how a visitor uses our website so that we can adjust and improve its ability to meet the visitor’s needs. A cookie does not collect any information that is not otherwise provided to Verdélite or a third-party service. Visitors can clear or disable cookies using tools on their web browsers.
Rights regarding personal information
Visitors to verdelite.ca have the right to know whether their personal information has been stored. They can ask Verdélite to learn about the contents and origin of this information, to verify its accuracy or to ask for it to be cancelled, updated or corrected. They can also request that it be made anonymous, and that any information held in violation of applicable law be blocked. Requests should be sent to Verdélite at the address noted below.
Information not contained in this policy
More details concerning the collection or processing of personal information may be requested from Verdélite at any time at the address noted below.
Mr. Mosgrove has over 15 years of sales and marketing leadership experience in commercial plan development and implementation, building top brands, and improving supply chain efficiencies in the Canadian alcohol beverage and cannabis sectors. He has led sales teams that enhanced revenue growth, gross margins and profitability, and key account satisfaction. Most recently, Mr. Mosgrove served as VP Sales & Marketing for TerrAscend Canada. Prior to this he held provincial sales manager roles in Ontario with Campari Canada, Escalade Wines & Spirits, Select Wine & Spirits and Bacardi Canada.
Mr. Jiwan is a data driven business leader with over 20 years experience in strategic development , sales and operations management , e-commerce, and developing data and business intelligence solutions. Before joining Emerald, he served in senior leadership positions, including Chief Information Officer and Chief Customer Officer, for established cannabis and healthcare companies, including senior roles at TerrAscend Corp and Shopper’s Drug Mart. With a strong marketing and customer orientation, he has strongly focused on operational excellence and implementing processes to function faster, smarter, and leaner.
Ms. Wong has over 30 years of quality and regulatory management experience in pharmaceutical and life science companies regulated to Canadian, US, European and international requirements. She has been responsible for establishing quality systems and ensuring regulatory compliance through all phases of product development from GPP, GLP, GCP, GMP for cannabis, pharmaceuticals, medical devices, combination products and biologicals. She was previously Executive Director of Quality Assurance at Novelion Therapeutics (formerly QLT Inc.) and worked for life science companies including MDS Nordion, Cangene Corporation, and Biomira Inc. Ms. Wong earned a B.Sc. (Microbiology) from the University of Alberta.
Ms. Hepburn has over a decade of experience in accounting and finance and is an experienced manager of privately and publicly traded manufacturing and mining businesses operating in Canada and the USA. Prior to joining Emerald, Ms. Hepburn was the Director of Finance and Administration at bioLytical Laboratories Inc., a medical diagnostics manufacturer. Before that, she held controller positions at junior gold and silver mining companies Northern Vertex Mining Corp., Kootenay Silver Inc. and Theia Resources Ltd. Ms. Hepburn earned a BBA from Simon Fraser University and her certification from the Certified Management Accountants of British Columbia.
Mr. Bandali’s expertise in global operations, strategy development, driving innovation, M&A, and investment management has been developed over a 25-year career in the life sciences sector spanning contract clinical and research services, analytical instrumentation, lab services and venture capital.
He holds an Advanced Management Program Degree from Harvard Business School, a Master of Business Administration from McGill University, and a Bachelor of Science from the University of British Columbia. He is an innovative business leader who has built strategic and operating plans that have resulted in rapid growth and significant profitability enhancement. He has managed businesses and operations with a global footprint and has led teams of over 900 people.
Mr. Bandali’s previous experience includes serving as President, Early Phase Clinical Services and Translational Science, Syneos Health; President, Early Stage Development, as well as Chief Innovation Officer, inVentiv Health Clinical; Senior Vice President, Strategy and Business Development, AB Sciex and Molecular Devices (part of Danaher Corporation); Senior Vice President, Strategy, Legal and Corporate Development, MDS Analytical Technologies; and Vice President and General Manager, Global Early Stage Development, MDS Pharma Services. He was also Venture Partner and Vice President at MDS Capital and has served on the boards of private and public companies.